Logo image of ALSPW.PA

SPINEWAY (ALSPW.PA) Stock Price, Quote, News and Overview

EPA:ALSPW - Euronext Paris - Matif - FR001400N2P2 - Common Stock - Currency: EUR

0.115  +0.02 (+23.79%)

ALSPW.PA Quote, Performance and Key Statistics

SPINEWAY

EPA:ALSPW (3/7/2025, 7:00:00 PM)

0.115

+0.02 (+23.79%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High3.8
52 Week Low0.07
Market Cap95.45K
Shares830.00K
Float830.00K
Yearly Dividend0
Dividend YieldN/A
PEN/A
Fwd PE0
Earnings (Next)03-24 2025-03-24/amc
IPO02-08 2013-02-08


ALSPW.PA short term performance overview.The bars show the price performance of ALSPW.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 40 -40 -60

ALSPW.PA long term performance overview.The bars show the price performance of ALSPW.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ALSPW.PA is 0.115 EUR. In the past month the price increased by 25.82%. In the past year, price decreased by -96.71%.

SPINEWAY / ALSPW Daily stock chart

ALSPW.PA Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 29.15 217.38B
IUI1.DE INTUITIVE SURGICAL INC 69.31 166.86B
BSX.DE BOSTON SCIENTIFIC CORP 39.18 133.56B
1BSX.MI BOSTON SCIENTIFIC CORP 39.52 133.38B
1MDT.MI MEDTRONIC PLC 17.48 113.17B
2M6.DE MEDTRONIC PLC 17.56 110.81B
1SHL.MI SIEMENS HEALTHINEERS AG 25.27 60.49B
BOX.DE BECTON DICKINSON AND CO 16.4 60.33B
SHL.DE SIEMENS HEALTHINEERS AG 23.49 59.08B
1EW.MI EDWARDS LIFESCIENCES CORP 26.07 39.21B
EWL.DE EDWARDS LIFESCIENCES CORP 26.65 37.76B
DC4.DE DEXCOM INC 48.5 28.81B

About ALSPW.PA

Company Profile

ALSPW logo image Spineway SA engages in the business of designing, producing, and selling spinal column implants and surgical instruments. The company is headquartered in Ecully, Auvergne-Rhone-Alpes and currently employs 54 full-time employees. The company went IPO on 2013-02-08. The company designs, produces, and sells spinal column implants and surgical instruments. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, among others. The Company’s sales are spread across France, Europe, Latin America, Asia and the Middle East and Africa.

Company Info

SPINEWAY

Batiment 7 7 Allee du Moulin Berger

Ecully AUVERGNE-RHONE-ALPES FR

Employees: 54

Company Website: https://spineway.com/

Phone: 33472770152

SPINEWAY / ALSPW.PA FAQ

What is the stock price of SPINEWAY today?

The current stock price of ALSPW.PA is 0.115 EUR. The price increased by 23.79% in the last trading session.


What is the ticker symbol for SPINEWAY stock?

The exchange symbol of SPINEWAY is ALSPW and it is listed on the Euronext Paris - Matif exchange.


On which exchange is ALSPW.PA stock listed?

ALSPW.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for SPINEWAY stock?

9 analysts have analysed ALSPW.PA and the average price target is 1.33 EUR. This implies a price increase of 1053.04% is expected in the next year compared to the current price of 0.115. Check the SPINEWAY stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SPINEWAY worth?

SPINEWAY (ALSPW.PA) has a market capitalization of 95.45K EUR. This makes ALSPW.PA a Nano Cap stock.


How many employees does SPINEWAY have?

SPINEWAY (ALSPW.PA) currently has 54 employees.


What are the support and resistance levels for SPINEWAY (ALSPW.PA) stock?

SPINEWAY (ALSPW.PA) has a support level at 0.1 and a resistance level at 0.13. Check the full technical report for a detailed analysis of ALSPW.PA support and resistance levels.


Is SPINEWAY (ALSPW.PA) expected to grow?

The Revenue of SPINEWAY (ALSPW.PA) is expected to decline by -15.91% in the next year. Check the estimates tab for more information on the ALSPW.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SPINEWAY (ALSPW.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SPINEWAY (ALSPW.PA) stock pay dividends?

ALSPW.PA does not pay a dividend.


When does SPINEWAY (ALSPW.PA) report earnings?

SPINEWAY (ALSPW.PA) will report earnings on 2025-03-24, after the market close.


What is the Price/Earnings (PE) ratio of SPINEWAY (ALSPW.PA)?

SPINEWAY (ALSPW.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-33.46).


ALSPW.PA Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to ALSPW.PA. When comparing the yearly performance of all stocks, ALSPW.PA is a bad performer in the overall market: 95.71% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ALSPW.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ALSPW.PA. Both the profitability and financial health of ALSPW.PA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALSPW.PA Financial Highlights

Over the last trailing twelve months ALSPW.PA reported a non-GAAP Earnings per Share(EPS) of -33.46. The EPS increased by 99% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -27.99%
ROE -37.63%
Debt/Equity 0.08
Chartmill High Growth Momentum
EPS Q2Q%99.95%
Sales Q2Q%20.31%
EPS 1Y (TTM)99%
Revenue 1Y (TTM)19.19%

ALSPW.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 87% to ALSPW.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 104.49% and a revenue growth -15.91% for ALSPW.PA


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts86.67
Price Target1.33 (1056.52%)
EPS Next Y104.49%
Revenue Next Year-15.91%